Mark Kirschbaum serves as Executive at Cyclacel Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Mark Kirschbaum has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 31, 2023 involved receiving (via award) 31,200 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 31, 2023 | CYCC | $0 | Award | 31,200 | $N/A | Discretionary |
Mark Kirschbaum currently holds 31,200 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Kirschbaum has been a net neutral trader of CYCC stock. They have purchased $0 and sold $0 worth of shares.
Mark Kirschbaum's most recent insider trade was on Jan 31, 2023, when they sold 31,200 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted